Skip to content

Clinical trials

Phase 3 Hemophilia A trials in South Africa

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemophilia A Phase: Phase 3 Country / region: South Africa Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20101
20113
20121
20141
20151
20164
20171
20182
20191
20202
20213
20222
20233
20241
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Active, not recruiting4
Recruiting4
Terminated3
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche7
Novo Nordisk A/S5
Bioverativ Therapeutics Inc.3
Genzyme, a Sanofi Company3
Pfizer3
Baxalta now part of Shire2
Bayer2
Laboratoire français de Fractionnement et de Biotechnologies2
BioMarin Pharmaceutical1
CSL Behring1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemophilia A30
Blood Coagulation Disorders5
Hemophilia B5
Coagulation Protein Disorders4
Hematologic Diseases4
Hemorrhagic Disorders4
Blood Coagulation Disorders, Inherited3
Genetic Diseases, Inborn3
Genetic Diseases, X-Linked2
Hemorrhage2

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.